Asthma can be suspected and treated in children as young as 1 year old, but a confident diagnosis is difficult to make before age 5 or 6. That’s because the gold-standard test for asthma, spirometry, requires a child to blow air forcefully into a tube on command, something most toddlers and preschoolers simply can’t do reliably. Before that age, doctors rely on symptom patterns, family history, allergy testing, and sometimes a trial of medication to see if symptoms improve.
Why Diagnosis Is Hard Before Age 5
The core challenge is that wheezing in young children is extremely common and usually not asthma. About 1 in 3 children has at least one wheezing episode before age 3. Many of these kids wheeze only during viral infections, and their symptoms disappear entirely by age 6 to 10. For years, any child who responded to a bronchodilator was often labeled as having asthma, but we now know that many of those children never develop the condition.
At the same time, underdiagnosis is a real problem. Some infants and toddlers do have genuine asthma, and delaying treatment means unnecessary suffering and potentially dangerous flare-ups. Doctors have to walk a line between starting treatment too early for something that will resolve on its own, and waiting too long for a child who truly needs it.
What Doctors Look For in Children Under 5
Since lung function tests aren’t practical for most kids under 5, physicians diagnose asthma in this age group based on a combination of symptom frequency, triggers, and risk factors. Canadian and U.S. guidelines suggest considering asthma in children ages 1 to 5 who have frequent asthma-like symptoms (8 or more days per month) or who have had two or more episodes of wheezing, coughing, or breathing difficulty.
The types of symptoms matter as much as the frequency. A cough that shows up during sleep, during physical activity, or after laughing and crying is more suspicious for asthma than one that only appears with a cold. Wheezing that happens outside of viral infections is also a stronger signal.
Doctors will often use a clinical scoring tool called the Modified Asthma Predictive Index (mAPI) to estimate whether a young child’s wheezing is likely to become persistent asthma. The criteria require four or more wheezing episodes in a year, plus at least one major factor or two minor ones:
- Major factors: a parent with physician-diagnosed asthma, the child having eczema (atopic dermatitis), or allergy testing showing sensitivity to an airborne allergen like dust mites or pet dander
- Minor factors: wheezing unrelated to colds, blood tests showing elevated eosinophils (a type of immune cell, at 4% or higher), or allergy to milk, egg, or peanuts
A child who meets these criteria has a significantly higher chance of still having asthma at school age and beyond.
The Role of Eczema and Allergies
One of the strongest early warning signs for asthma is eczema in infancy. Children with eczema at age 2 are roughly twice as likely to have asthma by age 6 compared to children without eczema. When eczema appears very early, before 4 months of age, the risk climbs even higher, with one study finding those children were about 4.5 times more likely to develop asthma by age 6.
This pattern is sometimes called the “atopic march,” a progression that often starts with food allergies and eczema in early childhood and later leads to asthma and nasal allergies. Not every child follows this path, but when a toddler has both eczema and recurrent wheezing, it strengthens the case for an asthma diagnosis.
When Lung Function Testing Becomes Possible
Standard spirometry, where a child takes a deep breath and blows out as hard and long as possible, works reliably in most children from age 6 onward. The technique is the same as in adults, and results can confirm whether airflow is obstructed and whether it improves after using a bronchodilator, both hallmarks of asthma.
Some pediatric centers can perform spirometry in preschoolers as young as 3 using modified techniques and child-friendly incentives (like blowing out virtual candles on a screen). Studies show that roughly 75% to 83% of children aged 3 to 6 can produce usable results in these specialized settings. However, this isn’t widely available in standard primary care offices, so it’s not something most families will encounter.
Another test, fractional exhaled nitric oxide (FeNO), measures a gas in the breath that rises when airways are inflamed in a specific way associated with asthma. In children, a reading above 35 parts per billion is considered elevated and supports an asthma diagnosis, while below 20 ppb makes allergic airway inflammation less likely. This test also requires cooperative breathing, which limits its use in very young children.
The “Trial of Treatment” Approach
For children under 5 who can’t do lung function tests, doctors often use a therapeutic trial to help confirm the diagnosis. This means prescribing asthma medication for a set period and watching whether symptoms improve. If a child’s wheezing, coughing, and breathing difficulty clearly get better with treatment and return when the medication stops, that response itself becomes evidence of asthma.
For children with mild, infrequent symptoms (less than 8 days per month), the trial may start with a quick-relief inhaler used as needed. Parents are asked to observe carefully whether it consistently and quickly relieves symptoms. For children with more frequent symptoms, occurring 2 or more days per week, or those who’ve had a moderate to severe flare-up, doctors typically prescribe a daily inhaled corticosteroid for several weeks. A convincing improvement followed by worsening when the medication is stopped points strongly toward asthma.
When Treatment Starts Before a Formal Diagnosis
In practice, many children under 5 begin asthma treatment before they have a definitive diagnosis, and guidelines support this approach when certain thresholds are met. U.S. guidelines recommend starting daily preventive therapy for infants and toddlers who’ve had four or more wheezing episodes in the past year, each lasting more than a day and disrupting sleep, combined with the risk factors described in the mAPI scoring above.
Daily treatment should also be considered for young children who need their rescue inhaler more than 2 days a week for more than 4 weeks, or who’ve had two flare-ups requiring oral steroids within 6 months. These benchmarks help doctors identify children whose symptoms are too frequent or severe to manage with a wait-and-see approach, even without a confirmed diagnosis.
The Royal Children’s Hospital Melbourne provides a useful practical summary: preschool asthma is defined as recurrent wheezing episodes (two or more) with cough or breathing difficulty that respond to asthma treatment. Most preschoolers have infrequent, mild, virus-triggered episodes with more than 6 weeks between them, and these children generally don’t need daily medication.
What Happens at School Age
Once a child reaches 5 or 6, the diagnostic picture becomes much clearer. Spirometry can confirm airway obstruction and its reversibility, FeNO testing becomes feasible, and the child has a longer symptom history to evaluate. Many children who wheezed as toddlers will have outgrown their symptoms by this point. Those who haven’t, particularly those with allergies, eczema, or a family history of asthma, are the ones most likely to carry a confirmed asthma diagnosis into adolescence and adulthood.
If your child has been wheezing since infancy and you’re still unsure whether it’s truly asthma, a formal evaluation with spirometry around age 5 to 6 can give you a much more definitive answer than was possible when they were younger.